Lysosomal Storage Disorders in Egyptian Children

Mohamed A Elmonem1,2,3, Iman G Mahmoud4,5, Dina A Mehaney6,4

  • 1Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. mohamed.abdelmonem@kasralainy.edu.eg.

Insights

This study details lysosomal storage disorders in Egyptian children, finding mucopolysaccharidoses most common. Many patients lack optimal diagnosis, highlighting the need for improved genetic services in Egypt.

Area of Science:

  • Medical Genetics
  • Pediatric Metabolism
  • Rare Diseases

Background:

  • Lysosomal storage disorders (LSDs) are a group of rare genetic conditions.
  • Accurate diagnosis and characterization of LSDs are crucial for patient management.
  • Limited data exists on the spectrum and prevalence of LSDs in Egypt.

Purpose of the Study:

  • To characterize the spectrum, relative frequency, and molecular basis of LSDs in Egyptian children.
  • To evaluate a selective screening program for LSD diagnosis.
  • To identify gaps in diagnostic and genetic services for LSDs in Egypt.

Main Methods:

  • A six-year retrospective evaluation (2008-2014) of 1,065 suspected children at Cairo University Children's Hospital.
  • Clinical, biochemical, and genetic assessments were performed.
  • Analysis of diagnosed LSDs, including specific types and detected mutations.

Main Results:

  • 211 children were diagnosed with 21 different LSDs.
  • Mucopolysaccharidoses (44.5%) were the most common group; Maroteaux-Lamy (17.1%), Gaucher (14.7%), and nephropathic cystinosis (13.7%) were most frequent.
  • 80 mutant alleles and 17 mutations were identified in 48 genetically assessed patients.

Conclusions:

  • This is the first report on the relative frequency and molecular data of LSDs in a large Egyptian cohort.
  • Over 80% of Egyptian LSD patients may lack access to optimal diagnosis.
  • Enhancing diagnostic and genetic services for LSDs in Egypt is essential.
Abstract

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.6K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.2K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328